SAB gets FDA fast track nod for experimental drug to treat influenza
HQ Team April 14, 2023: SAB Biotherapeutics got a fast-track designation from the USFDA for its investigational drug to treat influenza in high-risk
HQ Team April 14, 2023: SAB Biotherapeutics got a fast-track designation from the USFDA for its investigational drug to treat influenza in high-risk
HQ Team April 13, 2023: Alphabet Inc, Google’s parent company, has signed two new power purchase agreements in Belgium and the Netherlands to
HQ Team April 13, 2023: Fusion Pharmaceuticals, a Canada-based radiopharmaceuticals company, announced FDA clearance for its investigational new drug applications to treat solid
HQ Team April 13, 2023: Merck KGaA announced the USFDA had put a hold on the initiation of new patients to test its
HQ Team April 12, 2023: About 263 million children and young people worldwide are out of school, and achieving education for all by
HQ Team April 12, 2023: A 56-year-old woman from China’s Guangdong province died on March 16 after being infected with avian influenza, AH3N8,
HQ Team April 11, 2023: Astec LifeSciences, a subsidiary of Godrej Agrovet, opened its research and development centre in Rabale, Maharashtra, India, to